Licensing Success for Isis Outcomes
The Great Ormond Street Hospital for Children has become the 100th licensee this financial year of health questionnaires created in Oxford.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The Great Ormond Street Hospital for Children has become the 100th licensee this financial year of health questionnaires created in Oxford.
Oxford, UK: Oxford Photovoltaics, a company recently spun out from the University of Oxford by Oxford University Innovation Ltd., has developed new solar cell technology that is manufactured from cheap, abundant, non-toxic and non-corrosive materials and can be scaled to any volume.
After Amsterdam, New York, Rio de Janeiro, Copenhagen/Lund, Turin, Singapore, Glasgow and Madrid, the 9th Triple Helix International Conference will be organized for the first time in Silicon Valley - the world’s leading innovation and high-tech hub - by Stanford University’s Human Sciences and Technology Advanced Research Institute (H-STAR) on 11-14 July 2011.
Nokia commissioned Oxford University Consulting to put together a report into the secrets of online popularity. The Nokia Soci@lite Report, written by Dr. Bernie Hogan, investigates the secrets to the popularity of a new group of digital social media networkers, named ‘Soci@lites’ defined as people with 5,000 friends.
Oxford Electromagnetic Solutions Limited (OXEMS), which was spun out of the Department of Engineering Science of Oxford University by Oxford University Innovation in July 2010, has won a ‘Discovering Start-Ups 2010’ award, demonstrating that its new approach to detecting buried utility assets is recognised as an exciting innovation with great commercial potential.
A £1.55m fundraising round has been successfully completed by Crysalin Limited, a company founded as a spinout from the University of Oxford Biochemistry Department by Oxford University Innovation Limited.
Oxford University Consulting, a division within Oxford University Innovation Ltd., co-ordinates and supports access by external organisations to University academics and researchers for consulting assignments.
Oxford University Innovation Ltd, the technology transfer company of the University of Oxford, is pleased to announce its participation in the formation of IXO Therapeutics Ltd, a new biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases, which launches today.
Since November 2006 Isis Enterprise has been a ‘Carbon Trust Incubator Partner’ and we have been working closely with the Carbon Trust to build and develop a pipeline of low carbon innovations that have the potential to significantly reduce the UK’s carbon dioxide emissions.
Two recent studies at Oxford have highlighted the potential healthcare and economic benefits of personalising statin treatment based on a patient’s genetic risk to statin-induced myopathy. Researchers at Oxford have identified a biomarker which is highly associated with statin-induced myopathy that could form the basis of a diagnostic test for this side effect of statin use. Oxford University Innovation has filed a patent application based on this discovery and is looking for commercial partners to develop this test.